| MolName | (5Z)-3-cyclohexyl-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C26H26N4O3S2 |
| Smiles | OC(CNC(N=C1N2C=CC=C1)=C(/C=C(/C(N1C3CCCCC3)=O)\SC1=S)C2=O)c1ccccc1 |
| InChI | InChI=1S/C26H26N4O3S2/c31-20(17-9-3-1-4-10-17)16-27-23-19(24(32)29-14-8-7-13-22(29)28-23)15-21-25(33)30(26(34)35-21)18-11-5-2-6-12-18/h1,3-4,7-10,13-15,18,20,27,31H,2,5-6,11-12,16H2/t20-/m0/s1 |
| InChIK | JXYRERDXHLJMHX-FQEVSTJZSA-N |
| TotalMolweight | 506.649 |
| Molweight | 506.649 |
| MonoisotopicMass | 506.144631 |
| CLogP | 1.5986 |
| CLogS | -5.913 |
| H Acceptors | 7 |
| H Donors | 2 |
| TotalSurfaceArea | 374.53 |
| Relative PSA | 0.30636 |
| PolarSurfaceArea | 142.63 |
| Druglikeness | 0.94264 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.48571 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 1 |
| Rotatable Bond | 6 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 11 |
| Symmetricatoms | 4 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-3-cyclohexyl-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-cyclohexyl-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one